>MNTA – On page three of the annual report (not the 10-k portion) there is the following text at the end of the M356 update We made significant progress in this program in 2007 and look forward to substantial advancement in 2008<
My interpretation of substantial advancement is that MNTA expects to submit the M356 (generic Copaxone) ANDA during 2008.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”